What GLP-1 Medications Actually Do to Your Body GLP-1 (glucagon-like peptide-1) receptor agonists work by: Suppressing appetite and increasing feelings of fullness Slowing digestion so you feel satisfied longer Regulating blood sugar and insulin response Originally developed for type 2 diabetes, drugs like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro) are now widely prescribed for weight loss and the WHO formally recognises them as valid obesity treatments
KLOW provides a standardized tool for investigating these interconnected processes
Preproglucagon expressing neurons in the NTS project to many parts of the brain, including the hypothalamus, thalamus, parabrachial nucleus, parts of the mesolimbic dopamine system, raphe nucleus, amygdala, hippocampus and medial prefrontal cortex [32]
They can tell whether what you are seeing points to a real intolerance or is simply part of the newborn stage
Combining these effects generously suggests 5-8 pounds of potential weight loss, assuming optimal doses and individual responsiveness
